EWG Elevate’s Organon & Co OGN Stock Holding History

EWG Elevate’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-90	Closed	-$2.51K	–	541
2022 Q4	$2.51K	Buy	+90	New	+$2.3K	﹤0.01%	553

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

EWG Elevate's OGN Position: Q1 2023 in Review

EWG Elevate sold out of Organon & Co (OGN) in Q1 2023, closing a stake of 90 shares — an estimated $2.51K sold.

EWG Elevate first reported a position in OGN in Q4 2022 and held it in 1 quarter. The position peaked at $2.51K in Q4 2022. 767 funds tracked by Wall St. Rank hold OGN as of Q1 2023.

EWG Elevate reported no remaining Organon & Co position as of Q1 2023 after selling out during the quarter.
EWG Elevate sold 90 Organon & Co shares in Q1 2023, an estimated $2.51K.
EWG Elevate first reported a position in Organon & Co in Q4 2022 and held it in 1 quarter.
EWG Elevate's Organon & Co position peaked at $2.51K in Q4 2022.
767 funds tracked by Wall St. Rank held Organon & Co as of Q1 2023.

Based on EWG Elevate's 13F filing for Q1 2023, filed 13 Apr 2023.